Suzhou-based antibody discovery and development start-up Adagene Inc. has completed a US$28 million series B financing led by GP Healthcare Capital, according to a company announcement. New investor New World TMT and existing investors Eight Roads Ventures China, formerly Fidelity Growth Partners Asia, F-Prime Capital, formerly Fidelity Biosciences, and WuXi Corporate Venture Fund, also participated […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.